Category: General News

IPO Watchlist 10/26/26 – 10/30/26

10/30/2026 Aspen Neuroscience (ASPE) Price Range: $15.00 – $17.00 Bambusa Therapeutics, Inc. (BBTX) Price Range: $15.00 – $17.00 OPay Limited (OPAY Price Range: $19.00 – $21.00 Note: Micro-cap and small-cap offerings frequently experience sudden day-of delays or timeline extensions based on underwriter clearing. Keep a close eye on your brokerage platform if you intend to trade… Continue reading IPO Watchlist 10/26/26 – 10/30/26

Quarterly Reports 2026 10/26 – 10/30 Week 44

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/26/26 VZ Verizon Communications WELL Welltower CDNS Cadence Design Systems NUE Nucor PSA Public Storage HIG The Hartford Insurance Group, Inc. CLS Celestica CINF Cincinnati Financial BRO Brown & Brown PFG Principal Financial Group PKX POSCO Holdings Inc. CX Cemex SUI Sun Communities SMMT Summit Therapeutics… Continue reading Quarterly Reports 2026 10/26 – 10/30 Week 44

Telehealth Turns to GLP-1 Drugs for Addiction Treatment Before FDA Approval

A new use for popular weight-loss medications is gaining attention as telehealth companies begin prescribing GLP-1 drugs to patients seeking help with substance use disorders. According to an October 22, 2026, report from STAT News, some providers are exploring these medications as a potential treatment for addiction, even though the U.S. Food and Drug Administration… Continue reading Telehealth Turns to GLP-1 Drugs for Addiction Treatment Before FDA Approval

Tesla and SpaceX Merger Speculation Grows as Musk’s Flying Roadster Steals the Spotlight

Elon Musk’s latest automotive spectacle has done more than revive interest in Tesla’s long-delayed Roadster. It has also intensified speculation that Tesla and SpaceX could eventually merge, creating one of the most ambitious corporate combinations in modern business. The redesigned Roadster, unveiled October 15, features SpaceX-developed rocket-style thrusters that allow the vehicle to perform dramatic… Continue reading Tesla and SpaceX Merger Speculation Grows as Musk’s Flying Roadster Steals the Spotlight

Quarterly Reports 2026 10/19 – 10/23 Week 43

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/19/26 FITB Fifth Third Bancorp STLD Steel Dynamics WRB W.R. Berkley SMMT Summit Therapeutics CCK Crown Holdings AGNC AGNC Investment 10/20/26 GE GE Aerospace NFLX Netflix RTX RTX Corporation ISRG Intuitive Surgical CB Chubb Limited COF Capital One Financial MMM 3M GM General Motors NOC Northrop… Continue reading Quarterly Reports 2026 10/19 – 10/23 Week 43

Global Chip Sell-Off Deepens as Investors Question the AI Boom

The global technology sector suffered another sharp setback on Thursday, October 15, as investors continued pulling money out of semiconductor manufacturers and other companies tied to the artificial intelligence boom. What began as a retreat from highly valued technology stocks on Wall Street quickly spread across Asia and Europe, raising fresh questions about whether the… Continue reading Global Chip Sell-Off Deepens as Investors Question the AI Boom

Quarterly Reports 2026 10/12 – 10/16 Week 42

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/13/26 JPM JPMorgan Chase & Co. JNJ Johnson & Johnson UNH UnitedHealth Group GS The Goldman Sachs Group WFC Wells Fargo & Company C Citigroup DPZ Domino’s Pizza 10/14/26 ASML ASML Holding BAC Bank of America MS Morgan Stanley BLK BlackRock PGR The Progressive FAST Fastenal… Continue reading Quarterly Reports 2026 10/12 – 10/16 Week 42

Dividend Stocks: Can They Really Build a Lifetime of Passive Income?

For investors looking to build wealth over decades, dividend-paying stocks can be an attractive part of a portfolio. They offer something that stocks without dividends do not: a stream of cash payments simply for owning shares. But that does not automatically make dividend stocks better investments. The real question is whether an investor should prioritize… Continue reading Dividend Stocks: Can They Really Build a Lifetime of Passive Income?

IPO Watchlist 10/5/26 – 10/9/26

10/9/2026 TRex Bio (TRXB) Price Range: $14.00 – $16.00 Retension Pharmaceuticals (RTSN) Price Range: $11.00 – $13.00 Note: Micro-cap and small-cap offerings frequently experience sudden day-of delays or timeline extensions based on underwriter clearing. Keep a close eye on your brokerage platform if you intend to trade the debut.

Quarterly Reports 2026 10/5 – 10/9 Week 41

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/06/26 STZ Constellation Brands RPM RPM International 10/08/26 PEP PepsiCo 10/09/26 DAL Delta Air Lines Medium-cap 10/05/26 AEHR Aehr Test Systems 10/06/26 LW Lamb Weston PENG Penguin Solutions, Inc. NEOG Neogen 10/07/26 LEVI Levi Strauss & Co. APLD Applied Digital Corporation 10/08/26 NG Novagold Resources NRIX… Continue reading Quarterly Reports 2026 10/5 – 10/9 Week 41

LetsEncrypt SSL Secure Stripe Payment Processing